--- title: 博客 | GxP合规 description: GxP合规 | --- [![Logo PQE Group - azzurro - 2024](https://blog.pqegroup.com/hs-fs/hubfs/Logo%20PQE%20Group%20-%20azzurro%20-%202024.png?width=2000&height=721&name=Logo%20PQE%20Group%20-%20azzurro%20-%202024.png "Logo PQE Group - azzurro - 2024")](https://www2.pqegroup.com/cn/) - [主页](https://www2.pqegroup.com/cn/) - [行业](https://www2.pqegroup.com/cn/industry/) - [药品 & 活性成分](https://www2.pqegroup.com/cn/pharma-api/) - [医疗器械](https://www2.pqegroup.com/cn/medical-device/) - [生物技术](https://www2.pqegroup.com/cn/biotech/) - [初创企业](https://www2.pqegroup.com/cn/startup/) - [兽药](https://www2.pqegroup.com/cn/veterinary/) - [我们的服务](https://www2.pqegroup.com/cn/services/) - [数据完整性](https://www2.pqegroup.com/cn/data-integrity/) - [数字化管理](https://www2.pqegroup.com/cn/digital-governance/) - [工程](https://www2.pqegroup.com/cn/engineering/) - [调试、确认和验证 (CQV)](https://www2.pqegroup.com/cn/commissioning-qualification-validation/) - [质量合规](https://www2.pqegroup.com/cn/quality-compliance/) - [卓越实验室](https://www2.pqegroup.com/cn/laboratory-excellence/) - [药政事务](https://www2.pqegroup.com/cn/regulatory-affairs/) - [审计](https://www2.pqegroup.com/cn/audits/) - [临床研究](https://www2.pqegroup.com/cn/clinical-research/) - [培训](https://www2.pqegroup.com/cn/training/) - 关于 - [关于我们](https://www2.pqegroup.com/cn/about/) - [企业社会责任](https://www2.pqegroup.com/cn/about/csr/) - 资源中心 - [新闻 & 新闻稿件](https://www2.pqegroup.com/cn/news/) - [网络研讨会](https://www2.pqegroup.com/cn/webinars/) - [博客](https://blog.pqegroup.com/zh-cn) - [加入我们](https://www2.pqegroup.com/cn/careers/) - [联系我们](https://www2.pqegroup.com/cn/contact-us/) [主页](https://www2.pqegroup.com/cn/) [博客](https://blog.pqegroup.com/) # **最新文章** [GxP合规 ![](https://blog.pqegroup.com/hubfs/FDAs%20Pre-Approval%20Inspection_Site%20Banner.jpg)](https://blog.pqegroup.com/zh-cn/gxp-compliance/fda-pre-approval-inspection-pai-how-to-prepare-for-a-successful-outcome) 18 6月 2024 ## [FDA 批准前检查 (PAI) 如何为成功的结果做好准备--PQE 集团案例分析： PQE 集团成功辅助客户准备 FDA 批准前检查，提升质量标准，最终取得成功的案例分析。详细了解如何通过专业团队协作取得 FDA 批准。](https://blog.pqegroup.com/zh-cn/gxp-compliance/fda-pre-approval-inspection-pai-how-to-prepare-for-a-successful-outcome) [![twitter](https://blog.pqegroup.com/hubfs/twitter-1.png)](https://twitter.com/intent/tweet?text=FDA%20批准前检查%20(PAI)%20如何为成功的结果做好准备--PQE%20集团案例分析：&url=https://blog.pqegroup.com/zh-cn/gxp-compliance/fda-pre-approval-inspection-pai-how-to-prepare-for-a-successful-outcome) [GxP合规 ![](https://blog.pqegroup.com/hubfs/Quality%20Culture_Site%20Banner.jpg)](https://blog.pqegroup.com/zh-cn/gxp-compliance/evolution-of-quality-culture-in-pharma-from-initiatives-to-excellence) 12 2月 2024 ## [制药质量文化的演变：从主动到卓越 了解不同管理层级在确保质量方面的作用，以及如何在您的组织中建立强大的质量文化。](https://blog.pqegroup.com/zh-cn/gxp-compliance/evolution-of-quality-culture-in-pharma-from-initiatives-to-excellence) [![twitter](https://blog.pqegroup.com/hubfs/twitter-1.png)](https://twitter.com/intent/tweet?text=制药质量文化的演变：从主动到卓越&url=https://blog.pqegroup.com/zh-cn/gxp-compliance/evolution-of-quality-culture-in-pharma-from-initiatives-to-excellence) [GxP合规 ![](https://blog.pqegroup.com/hubfs/Biotech%20Products_banner%20insight.jpg)](https://blog.pqegroup.com/zh-cn/gxp-compliance/cleaning-validation-biotech) 14 3月 2023 ## [生物制品和下一代清洁策略的挑战 通过一篇文章，了解生物制品清洁验证中会面临的主要挑战。](https://blog.pqegroup.com/zh-cn/gxp-compliance/cleaning-validation-biotech) [![twitter](https://blog.pqegroup.com/hubfs/twitter-1.png)](https://twitter.com/intent/tweet?text=生物制品和下一代清洁策略的挑战&url=https://blog.pqegroup.com/zh-cn/gxp-compliance/cleaning-validation-biotech) [GxP合规 附录一 ![](https://blog.pqegroup.com/hubfs/Annex-1-Critical-Utilities-technical-qualification-GMP-compliance.jpg)](https://blog.pqegroup.com/zh-cn/annex-1/new-annex-1-critical-utilities-gmp-compliance) 15 2月 2023 ## [关键公用工程的GMP合规性和新版附录一 了解新版附录一以及关键公用工程在更广泛的污染控制战略中的作用。](https://blog.pqegroup.com/zh-cn/annex-1/new-annex-1-critical-utilities-gmp-compliance) [![twitter](https://blog.pqegroup.com/hubfs/twitter-1.png)](https://twitter.com/intent/tweet?text=关键公用工程的GMP合规性和新版附录一&url=https://blog.pqegroup.com/zh-cn/annex-1/new-annex-1-critical-utilities-gmp-compliance) ### 分类 - [GxP合规 (4)](https://blog.pqegroup.com/zh-cn/tag/gxp合规) - [医疗器械 (1)](https://blog.pqegroup.com/zh-cn/tag/医疗器械) - [女性科技(FemTech) (6)](https://blog.pqegroup.com/zh-cn/tag/女性科技femtech) - [工程 (1)](https://blog.pqegroup.com/zh-cn/tag/工程) - [药政事务 (1)](https://blog.pqegroup.com/zh-cn/tag/药政事务) - [计算机化系统验证和数据完整性 (5)](https://blog.pqegroup.com/zh-cn/tag/计算机化系统验证和数据完整性) - [调试、确认和验证 (CQV) (1)](https://blog.pqegroup.com/zh-cn/tag/调试-确认和验证-cqv) - [附录一 (4)](https://blog.pqegroup.com/zh-cn/tag/附录一) 查看所有话题 ### 注目記事Top 5 ### [领英](https://www.linkedin.com/company/pqe-group/) ![PQE Group](https://blog.pqegroup.com/hubfs/logo%20PQE%20Group%20+%20payoff-BLUE.svg) 自1998年起，PQE就通过了ISO 9001质量体系认证。 扫描关注PQE微信公众号。 ![PQE Group wechat weixin](https://blog.pqegroup.com/hs-fs/hubfs/PQE%20Group%20wechat%20weixin.jpg?width=127&height=127&name=PQE%20Group%20wechat%20weixin.jpg)   - 探索 - [加入PQE](https://www2.pqegroup.com/cn/careers/) - [全球分支](https://www2.pqegroup.com/cn/contact-us/#locations) - [关于](https://www2.pqegroup.com/cn/about/) - [博客](https://blog.pqegroup.com/zh-cn) - 相关链接 - [隐私政策](https://www2.pqegroup.com/privacy-notice/) - [Cookie政策](https://www2.pqegroup.com/cookie-policy/) - [组织模式](https://www2.pqegroup.com/cn/model-of-organization/) - [道德守则](https://www2.pqegroup.com/ethical-code/) English - [简体中文](https://blog.pqegroup.com/zh-cn/tag/gxp合规) - [Deutsch](https://blog.pqegroup.com/de/tag/gxp-compliance) - [English](https://blog.pqegroup.com/tag/gxp-compliance) - [Español - España](https://blog.pqegroup.com/es-es/tag/cumplimiento-gxp) - [Español - México](https://blog.pqegroup.com/es-mx/tag/cumplimiento-de-buenas-practicas) - [Français](https://blog.pqegroup.com/fr/tag/gxp-compliance) - [Polski](https://blog.pqegroup.com/pl/tag/zgodność-gxp) - [Português - Brasil](https://blog.pqegroup.com/pt-br/tag/conformidade-em-qualidade) - [Русский](https://blog.pqegroup.com/ru/tag/соответствие-gxp) - [עברית](https://blog.pqegroup.com/he/tag/תאימות-ל-gxp) - [日本語](https://blog.pqegroup.com/ja/tag/gxpコンプライアンス) 切换语言 Copyright 2023 | 上海彼科意企业管理咨询有限公司 [LinkedIn](https://www.linkedin.com/company/pqe-group) [![twitter](https://blog.pqegroup.com/hubfs/twitter-w.png) Twitter](https://twitter.com/PQEGroup) [Facebook](https://www.facebook.com/PQEGroup/) [Instagram](https://www.instagram.com/lifeatpqe) [YouTube](https://www.youtube.com/c/PQEGroup) [Xing](https://www.xing.com/pages/pqegroup)